Print This Post
If you have work you want to share with the neurodegeneration research community, submissions are now open for the AD/PD™ 2027 International Conference on Alzheimer’s and Parkinson’s Diseases, and the deadline is 1 September 2026.
The AD/PD Conference runs from 16 to 20 March 2027 in Barcelona, Spain, as a hybrid event with an online option for anyone who can’t travel. It’s one of the larger gatherings in the field, bringing together basic scientists and clinical researchers across Alzheimer’s, Parkinson’s and related disorders, with a focus on where these diseases overlap. This is the 21st edition of the conference.
A few things worth knowing before you submit:
Abstracts are limited to 280 words and need to follow a set structure: objectives, methods, results and conclusions. The title can run up to 20 words, in upper case. You can include tables, graphs and images, though these count towards your word limit (images are exempt). Each person can present up to five posters and one oral presentation, but there’s no cap on how many abstracts you submit or how many you’re listed on as a co-author.
If you’re an early career researcher, the Junior Faculty Awards are open to graduate students (PhD, MD) and junior scientists up to five years post-doctorate. If you want to be considered, upload your supporting documents when you submit, as you can’t add them later.
Two more points that matter for ECRs. Submitted abstracts must contain unpublished data, and anything previously presented won’t be accepted. And AD/PD™ has no embargo policy, so once your work is in, you’re free to share and promote it across your own networks.
Accepted authors will be notified in mid-October 2026. The presenting author needs to be a registered participant, and all accepted abstracts are published on the conference website ahead of the event.
You can read the full submission rules and start your abstract on the AD/PD™ 2027 abstract submission page.
